Long noncoding RNA LOC646029 functions as a ceRNA to suppress ovarian cancer progression through the miR-627-3p/SPRED1 axis
作者机构:State Key Laboratory of Molecular OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing100021China Department of Gynecological OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing100021China Department of Obstetrics and GynecologyThe Affiliated Hospital of Qingdao UniversityQingdao266000China
出 版 物:《Frontiers of Medicine》 (医学前沿(英文版))
年 卷 期:2023年第17卷第5期
页 面:924-938页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
基 金:supported by the National Key R&D Program of China (No.2021YFC2501000) the CAMS Innovation Fund for Medical Sciences (Nos.2021-I2M-1-018 and 2021-12M-1-067)
主 题:0varian cancer lncRNA LOC646029 metastasis microRNA 627-3p SPRED1
摘 要:Long noncoding RNAs(lncRNAs)play a crucial regulatory role in the development and progression of multiple ***,the potential mechanism by which lncRNAs affect the recurrence and metastasis of ovarian cancer remains *** the current study,the lncRNA LOC646029 was markedly downregulated in metastatic ovarian tumors compared with primary ***-and loss-of-function assays demonstrated that LOC646029 inhibits the proliferation,invasiveness,and metastasis of ovarian cancer cells in vivo and in ***,the downregulation of LOC646029 in metastatic ovarian tumors was strongly correlated with poor ***,LOC646029 served as a miR-627-3p sponge to promote the expression of Sprouty-related EVH1 domain-containing protein 1,which is necessary for suppressing tumor metastasis and inhibiting KRAS ***,our results demonstrated that LOC646029 is involved in the progression and metastasis of ovarian cancer,which may be a potential prognostic biomarker.